참고문헌
- Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003; 361:151-60. https://doi.org/10.1016/S0140-6736(03)12193-9
- Giustizieri ML, Mascia F, Frezzolini A, De Pita O, Chinni LM, Giannetti A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol. 2001; 107:871-7. https://doi.org/10.1067/mai.2001.114707
- Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004; 113: 651-7. https://doi.org/10.1172/JCI21060
- Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003; 112:1195-202. https://doi.org/10.1016/j.jaci.2003.08.049
- Beresford L, Orange O, Bell EB, Miyan JA. Nerve fibres are required to evoke a contact sensitivity response in mice. Immunology. 2004; 111:118-25. https://doi.org/10.1111/j.1365-2567.2004.01786.x
- Levy R, Dilley J, Fox RI, Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A. 1979; 76:6552-56 https://doi.org/10.1073/pnas.76.12.6552
- Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ, et al. CD99 engagement on human peripheral blood T cells results in TCR/ CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol. 1998; 161:4671-78.
- Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim M, et al. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J Immunol. 2001; 166:787-94. https://doi.org/10.4049/jimmunol.166.2.787
- Sciandra M, Marino MT, Manara MC, Guerzoni C, Grano M, Oranger A, et al. CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. J. Bone Miner. Res. 2014; 29:1295-309. https://doi.org/10.1002/jbmr.2141
- Sohn HW, Choi EY, Kim SH, Lee IS, Chung DH, Sung UA, et al. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. Am J Pathol. 1998; 153:1937-45. https://doi.org/10.1016/S0002-9440(10)65707-0
- Husak Z, Printz D, Schumich A, Potschger U, Dworzak MN. Death induction by CD99 ligation in TEL/AML1-positive acute lymphoblastic leukemia and normal B cell precursors. J Leukoc Biol. 2010; 88:405-12. https://doi.org/10.1189/jlb.0210097
- Husak Z, Dworzak MN. CD99 ligation upregulates HSP70 on acute lymphoblastic leukemia cells and concomitantly increases NK cytotoxicity. Cell Death Dis. 2012; 3:e425. https://doi.org/10.1038/cddis.2012.164
- Bernard A, Aubrit F, Raynal B, Pham D, Boumsell L. A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes. J Immunol. 1988; 140:1802-07.
- Gelin C, Aubrit F, Phalipon A, Raynal B, Cole S, Kaczorek M, et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 1989; 8:3253-59. https://doi.org/10.1002/j.1460-2075.1989.tb08485.x
- Bernard G, Zoccola, D, Deckert M, Breittmayer JP, Aussel C, Bernard A. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J Immunol. 1995; 154:26-32.
- Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol. 1997; 159:2250-58.
- Hahn MJ, Yoon SS, Sohn HW, Song HG, Park SH, Kim TJ. Differential activation of MAP kinase family members triggered by CD99 engagement. FEBS Lett. 2000; 470:350-4. https://doi.org/10.1016/S0014-5793(00)01330-2
-
Lee KJ, Kim Y, Yoo YH, Kim MS, Lee SH, Kim CG, et al. CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of
${\beta}1$ Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway. Mol Cell Biol. 2017; 37:675-16 - Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat J Immunol. 2002; 3:143-50.
- Lou O, Alcaide P, Luscinskas FW, Muller WA. CD99 is a key mediator of the transendothelial migration of neutrophils. J Immunol. 2007; 178:1136-43. https://doi.org/10.4049/jimmunol.178.2.1136
- Bixel G, Kloep S, Butz S, Petri B, Engelhardt B, Vestweber D. Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood. 2004; 104:3205-13.
- Byun HJ, Hong IK, Kim E, Jin YJ, Jeoung DI, Hahn JH, et al. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. J Biol Chem. 2006; 281:34833-47. https://doi.org/10.1074/jbc.M605483200
- Cotter TG, Keeling PJ, Henson PM. A monoclonal antibodyinhibiting FMLP-induced chemotaxis of human neutrophils. J Immunol. 1981; 127:2241-5.
- Wu BC, Lee AH, Hancock REW. Mechanisms of the Innate Defense Regulator Peptide-1002 Anti-Inflammatory Activity in a Sterile Inflammation Mouse Model. J Immunol. 2017; 199:3592-3603. https://doi.org/10.4049/jimmunol.1700985
- Sahu RP, Rezania S, Ocana JA, DaSilva-Arnold SC, Bradish JR, Richey JD, et al. Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin. PLoS One. 2014; 9:e111608. https://doi.org/10.1371/journal.pone.0111608
- Kim MJ, Kim YY, Choi YA, Baek MC, Lee B, Park PH, et al. Elaeocarpusin Inhibits Mast Cell-Mediated Allergic Inflammation.Front Pharmacol. 2018; 9:591 https://doi.org/10.3389/fphar.2018.00591
-
Lee KJ, Lim D, Yoo YH, Park EJ, Lee SH, Yadav BK, et al. Paired Ig-like type 2 receptor-derived agonist ligands ameliorate inflammatory reactions by downregulating
${\beta}1$ integrin activity. Mol Cells. 2016; 39:557-65. https://doi.org/10.14348/molcells.2016.0079